Project Grant K23AR086325
- Federal Grant Award Summary The University of Washington received a $412,569 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective May 1, 2026 through April 30, 2028. The funded research addresses inflammatory cell death mechanisms in Systemic Lupus Erythematosus (SLE) by developing and validating bioassays to detect pyroptosis, necroptosis, and...
- Federal Project Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $1.317 million Project Grant award (obligated September 19, 2025; completion August 31, 2030) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award funds a basic research initiative investigating bone remodeling mechanisms in response to aerobic exercise...
- Federal Grant Award Summary The University of Michigan, through its Office of Research and Sponsored Projects, received a $172,720 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award, effective May 1, 2026 through April 30, 2031, funds basic research investigating neutrophil mitophagy (dysfunctional mitochondrial autophagy) as a pathogenic...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $553,640 Project Grant to the University of Wisconsin–Madison, effective June 1, 2026 through April 30, 2031, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This award funds basic research investigating the role of the H3K27 demethylase enzyme JMJD3 (Jumonji domain-containing protein D3) as a molecular transducer of...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded $401,625.00 to the University of California, Los Angeles (UCLA) on March 15, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to conduct a mechanistic ancillary study embedded within an ongoing randomized clinical trial. The project, which runs through December 31, 2029, investigates the combined effects of exercise and oral...
- Federal Project Grant Award Summary Washington State University received a $1,407,925 Project Grant awarded on August 12, 2025, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The research project, "Molecular Mechanisms of TAK1 Regulation in Rheumatoid Arthritis," will be conducted through July 31, 2028, and focuses on investigating how transforming growth...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $172,034 Project Grant to the University of Nebraska Medical Center on August 15, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This research initiative, with a completion date of June 30, 2030, focuses on identifying molecular and epidemiologic determinants of myocardial dysfunction and heart failure (HF) in patients with...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the University of Delaware a $666,825 Project Grant on September 1, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to investigate the structural and functional roles of muscle-subtendon units in Achilles tendinopathy. The research will extend through June 30, 2030, utilizing advanced biomechanical sensors, magnetic resonance imaging...
- Federal Project Grant Award Summary Fred Hutchinson Cancer Center received a $124,308 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), with an award date of September 15, 2025 and completion date of August 31, 2027. The funded research will investigate the pathogenic mechanisms of Facioscapulohumeral Muscular Dystrophy (FSHD), the third most common form...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Leland Stanford Junior University a $154,000 Project Grant effective August 1, 2025, through July 31, 2027, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This award supports research applying service design methods to enhance the implementation and adoption of iGET Living, a digital graded exposure treatment (GET)...
The University of Washington's Office of Sponsored Programs received a $169,668 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective July 1, 2026 through April 30, 2031. The award supports a K23 career development research project investigating tailored exercise interventions for patients with axial spondyloarthritis (axSpA), with particular focus on sex-based differences in disease outcomes. The research will deliver three primary products: (1) longitudinal analysis quantifying the optimal dose of physical activity that predicts clinically significant improvement in disease activity and function, stratified by patient sex using data from established axSpA cohorts; (2) qualitative research findings identifying barriers and facilitators to regular physical activity and exercise participation by sex; and (3) feasibility and acceptability data from a pilot randomized controlled trial evaluating personalized physical therapy exercises delivered via the ExerciseRx mobile application. The award will advance the candidate's development as an independent clinical investigator in rheumatology by providing critical training in longitudinal analysis, qualitative research methods, and clinical trial management. The concurrent design of the pilot trial with qualitative research activities will enable iterative refinement based on participant feedback, ultimately generating evidence to support development of an effective, sex-tailored exercise program to improve clinical outcomes for both female and male patients with axSpA, addressing documented disparities in treatment response and disease management adherence.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $169.7k | 6/23/26 |